MIRA - MIRA Pharmaceuticals, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
1.32 0.91 (68.94%)	-0.03 (-1.33%)	0.0 (0.0%)	0.0 (0.0%)	0.01 (0.73%)	-0.01 (-0.75%)	0.9 (67.67%)	0.9 (67.67%)

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.09
Diluted EPS:: -0.09
Basic P/E:: -24.7778
Diluted P/E:: -24.7778
RSI(14) 1m:: 26.82
VWAP:: 2.25
RVol:

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	2.12 -0.03 (-1.4%)	Oct 15 17:23
1m	Price increase 1m	2.15 +0.14 (+6.97%)	Oct 15 17:22
1m	Price increase 1m	2.01 +0.06 (+3.08%)	Oct 15 17:21
10m	Price increase 10m	2.01 +0.08 (+4.15%)	Oct 15 17:21
1m	Price increase 1m	2.01 +0.06 (+3.08%)	Oct 15 17:21